IQVIA, along with the @NBA, was awarded the #UNIVANTS of Healthcare Excellence Award for partnership on the 2020 “NBA Bubble.” We’re proud to be recognized for the collaboration between our epidemiologists, data scientists, operational and technical teams. https://t.co/l9QQRbyPay
Important paper from @yhgrad, @cdefilippomack and colleagues studying COVID in the NBA during Omicron: Receiving a booster decreased the risk of infection by 57% and symptomatic infection by 61%. Boosters provide some protection against infection.
https://t.co/3Dnp47rrLj
@ProfEmilyOster Worth reading this article about an incredible woman and the kind of working mom I want to be. I love her story about traveling with her kids. Arms around you, Emily, and deep condolences for your loss.
NEWS: The NFL is launching a "significant call to action" in response to disproportionately high injury rates on special teams. Rule changes and new training requirements are on the table for punts and potentially kickoffs.
Join IQVIA’s Dr. Christina Mack and other medical experts for @NFL’s discussion of how data and science drove key pandemic decisions during the 2021 season. Hosted by Dr. Allen Sills, NFL CMO, on Tuesday, February 8: https://t.co/iBHz2RHt8G
Pac-12 Network analyst @AdamsonAshley joins The Drive to discuss the CFB year in review, the Utes Rose Bowl run, a memorable season, TV returns, looking ahead to 2022 + more
https://t.co/fAQtSgH0Jk
Policy insight from NBA reinfections supports holding people out of routine PCR surveillance for 90 days after natural infection.
Case Series from a 12-Month Longitudinal NBA Cohort @NBAOfficial@robbysikka @NathanGrubaugh @cdefilippomack @IQVIA_US
https://t.co/L4hZvQidas
New preprint: Ct value trajectories from 97 Omicron infections detected in the @NBA testing cohort: https://t.co/elpiZTP9Xr
1) High % had Ct<30 at day 5 post detection
2) Omicron had lower peak viral load and more variable early viral growth durations than Delta
1/13